Your browser doesn't support javascript.
loading
Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.
Fiebelkorn, Amy Parker; Coleman, Laura A; Belongia, Edward A; Freeman, Sandra K; York, Daphne; Bi, Daoling; Kulkarni, Ashwin; Audet, Susette; Mercader, Sara; McGrew, Marcia; Hickman, Carole J; Bellini, William J; Shivakoti, Rupak; Griffin, Diane E; Beeler, Judith.
Afiliação
  • Fiebelkorn AP; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Coleman LA; Marshfield Clinic Research Foundation, Wisconsin.
  • Belongia EA; Marshfield Clinic Research Foundation, Wisconsin.
  • Freeman SK; Marshfield Clinic Research Foundation, Wisconsin.
  • York D; Marshfield Clinic Research Foundation, Wisconsin.
  • Bi D; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Kulkarni A; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring.
  • Audet S; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring.
  • Mercader S; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • McGrew M; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Hickman CJ; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Bellini WJ; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Shivakoti R; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Griffin DE; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Beeler J; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring.
J Infect Dis ; 213(7): 1115-23, 2016 Apr 01.
Article em En | MEDLINE | ID: mdl-26597262
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Vacina contra Sarampo-Caxumba-Rubéola / Anticorpos Neutralizantes / Imunidade Celular / Vírus do Sarampo / Anticorpos Antivirais Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Vacina contra Sarampo-Caxumba-Rubéola / Anticorpos Neutralizantes / Imunidade Celular / Vírus do Sarampo / Anticorpos Antivirais Idioma: En Ano de publicação: 2016 Tipo de documento: Article